These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33983592)

  • 1. Breast Cancer-Related Low Penetrance Genes.
    Kang D; Choi JY
    Adv Exp Med Biol; 2021; 1187():419-434. PubMed ID: 33983592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
    Boujemaa M; Mighri N; Chouchane L; Boubaker MS; Abdelhak S; Boussen H; Hamdi Y
    PLoS One; 2022; 17(3):e0265638. PubMed ID: 35333900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk of breast cancer.
    Nasir A; Shackelford RE; Anwar F; Yeatman TJ
    Minerva Endocrinol; 2009 Dec; 34(4):295-309. PubMed ID: 20046159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
    Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
    Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population.
    Osorio A; Rodríguez-López R; Díez O; de la Hoya M; Ignacio Martínez J; Vega A; Esteban-Cardeñosa E; Alonso C; Caldés T; Benítez J
    Int J Cancer; 2004 Jan; 108(1):54-6. PubMed ID: 14618615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
    Vanderwal A; Lewis J; Basil J; Atzinger C; Widmeyer K
    J Genet Couns; 2023 Jun; 32(3):674-684. PubMed ID: 36642783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to breast cancer.
    Bradbury AR; Olopade OI
    Rev Endocr Metab Disord; 2007 Sep; 8(3):255-67. PubMed ID: 17508290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low penetrance breast cancer predisposition SNPs are site specific.
    Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C; Margolin S
    Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes.
    Nusbaum R; Vogel KJ; Ready K
    Breast Dis; 2006-2007; 27():21-50. PubMed ID: 17917139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?
    Ghoussaini M; Pharoah PDP; Easton DF
    Am J Pathol; 2013 Oct; 183(4):1038-1051. PubMed ID: 23973388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer genome-wide association studies: there is strength in numbers.
    Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
    Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.
    Downs B; Sherman S; Cui J; Kim YC; Snyder C; Christensen M; Luo J; Lynch H; Wang SM
    Eur J Cancer; 2019 Jan; 107():68-78. PubMed ID: 30551077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
    Sapkota Y
    Cytogenet Genome Res; 2014; 144(2):77-91. PubMed ID: 25401968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic susceptibility to breast cancer: current state-of-the-art.
    Ghoussaini M; Pharoah PD
    Future Oncol; 2009 Jun; 5(5):689-701. PubMed ID: 19519208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA and Breast Cancer-Related High-Penetrance Genes.
    Han SA; Kim SW
    Adv Exp Med Biol; 2021; 1187():473-490. PubMed ID: 33983595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.